E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT05722561
Phase
PHASE2
Status
Recruiting

Conditions

  • Cigarette Smoking
  • Opioid Use Disorder

Eligibility Criteria

Sex
ALL
Age
21 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Telehealth Motivational Counseling — BEHAVIORAL
    At baseline, after randomization, participants will receive their first telehealth session (20\~25 minutes) from a counselor trained in motivational interviewing, harm reduction, and smoking cessation. Four additional sessions will be delivered (weeks 2, 3, 4, 6), 15\~20 minutes each.
  • Nicotine Replacement Product — DRUG
    Combination nicotine replacement therapy with lozenges and patches. Participants are recommended to use the NRT according to product directions.
  • National Institute on Drug Abuse (NIDA) Standardized Research Electronic Cigarette (SREC). — DEVICE
    Participants are to use the electronic cigarette freely as replacement for smoking combustible cigarettes.

Study Details

The purpose of this an open-label, randomized controlled trial study is to compare the effectiveness of electronic cigarettes (e-cigarettes/e-cigs) versus telehealth motivational counseling with combination nicotine replacement therapy (NRT) + telehealth counseling on combustible cigarettes smoking reduction among persons with opioid use disorder (OUD) in methadone and buprenorphine treatment programs (opioid use disorder treatment programs (OUDTP)). OUDTP patients are a population with exceptionally high combustible cigarettes smoking burden and yet limited success in achieving meaningful clinical outcomes in tobacco treatment. If effective, electronic cigarettes would provide an additional tool for tobacco harm reduction among this difficult-to-treat vulnerable population.

Key Dates

Start date
Aug 8, 2024
Status verified
Mar 2026
Primary completion
Nov 1, 2026
Completion
Mar 1, 2027

Study Design

Enrollment
302 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Electronic Cigarette
    Participants in the Electronic Cigarette (EC) arm will receive telehealth motivational counseling for 5 weeks plus the standardized research e-cigarette (SREC).
  • Active Comparator: Nicotine Replacement Therapy
    Participants in the Nicotine Replacement Therapy (NRT) arm will receive telehealth motivational counseling plus combination NRT (patch and lozenge).

Primary Outcome Measure

Percentage of Participants who Achieve 100% Reduction in Cigarettes Per Day (CPD) between Baseline and End of Intervention (Visit 5) [ Time Frame: Up to Visit 5 (Day 56) ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016
Omar El-Shahawy
646-501-3587
Albert Einstein College of MedicineThe BronxNew York10461
Shadi Nahvi, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

Related Studies